Fundz

arcoris bio raises CHF 6.3 million seed round to enhance its MUSE® biomarker technology, co-led by Ventura Ace and ZEISS Ventures.

PRIVATENov 06, 2025

Amount Raised

CHF6.3 Million

Round Type

Seed

SchlierenBiotechnologyresearch

Investors

Zürcher KantonalbankVentura AceZeiss Ventures

Description

arcoris bio has secured CHF 6.3 million in a seed financing round to advance its MUSE® biomarker detection platform. The round was co-led by Ventura Ace and ZEISS Ventures, with additional participation from Zürcher Kantonalbank and private investors. The funding will help industrialize the platform and expand strategic partnerships. This milestone is set to accelerate the launch of new products in digital pathology.

Quick answer

arcoris bio raised CHF6.3 Million in a Seed round, dated November 6, 2025. Investors: Zürcher Kantonalbank, Ventura Ace and Zeiss Ventures. arcoris bio is based in Schlieren, Zurich, Switzerland.

How much did arcoris bio raise?
arcoris bio raised CHF6.3 Million in a Seed round on November 6, 2025.
Who invested in arcoris bio?
Zürcher Kantonalbank, Ventura Ace and Zeiss Ventures are named as investors in this round.
What does arcoris bio do?
arcoris bio develops next-generation technologies for biomarker detection in research and diagnostics.
Where is arcoris bio based and how big is it?
arcoris bio is based in Schlieren, Zurich, Switzerland. Fundz records about 6 employees.
Who are the decision-makers at arcoris bio?
Fundz holds 1 contact at arcoris bio, including the CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as arcoris bio that raised within 45 days of this round, from Fundz verified event records.

  • Anomaly Bio raised $2.6M (Pre-Seed) on November 12, 2025.
  • IBI Ag raised $10M (Series A) on November 11, 2025.
  • Brainstorm Cell Therapeutics raised $155K (Convertible Note) on November 6, 2025.
  • Hepta raised $6.7M (Seed) on November 5, 2025.
  • nextProtein raised $21M (Series B) on November 4, 2025.
  • AAVantgarde Bio raised $141M (Series B) on November 3, 2025.

Who to call at arcoris bio, and when

A new round usually means arcoris bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day arcoris bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at arcoris bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at arcoris bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

arcoris bio

Location

Schlieren, Zurich, Switzerland

About

arcoris bio develops next-generation technologies for biomarker detection in research and diagnostics. Its flagship MUSE® platform provides universal, programmable signal amplification to enable highly sensitive and multiplex assays that drive the future of digital pathology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment arcoris bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMatyas V., CEOSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for arcoris bio's next move

See what Strategic adds

arcoris bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.